Showing 4861-4880 of 7110 for: Cochrane Systematic Reviews Back
- Pharmacological and non‐pharmacological strategies for obese women with subfertility
Cochrane Systematic Reviews, 25-Mar-2021
Clinicians primarily recommend weight loss for obese women seeking pregnancy. The effectiveness of interventions aimed at weight loss in obese women with subfertility is unclear.
- Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V)
Cochrane Systematic Reviews, 12-Nov-2014
McArdle disease (Glycogen Storage Disease type V) is caused by an absence of muscle phosphorylase leading to exercise intolerance, myoglobinuria rhabdomyolysis and acute renal failure. This is an update of a review first published in 2004.
- Pharmacological cardioversion for atrial fibrillation and flutter
Cochrane Systematic Reviews, 8-Sep-2008
Atrial fibrillation is the commonest cardiac dysrhythmia. It is associated with significant morbidity and mortality. There are two approaches to the management of atrial fibrillation: controlling the ventricular rate or converting to sinus rhythm in the e
- Pharmacological interventions for antisocial personality disorder
Cochrane Systematic Reviews, 3-Aug-2010
Antisocial personality disorder (AsPD) is associated with a wide range of disturbance including persistent rule-breaking, criminality, substance misuse, unemployment, homelessness and relationship difficulties.
- Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users
Cochrane Systematic Reviews, 15-Mar-2018
Prolonged treatment with benzodiazepines is common practice despite clinical recommendations of short-term use. Benzodiazepines are used by approximately 4% of the general population, with increased prevalence in psychiatric populations and the elderly. A
- Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings
Cochrane Systematic Reviews, 18-Jun-2013
The items with X are considered "more relevant", that is the review has to stick to them to allow publication. The others have to be considered as strong suggestions to improve the readability and clarity of the review, but the reviewers can consider if
- Pharmacological interventions for borderline personality disorder
Cochrane Systematic Reviews, 11-May-2010
Drugs are widely used in borderline personality disorder (BPD) treatment, chosen because of properties known from other psychiatric disorders ("off-label use"), mostly targeting affective or impulsive symptom clusters.
- Pharmacological interventions for clozapine-induced hypersalivation
Cochrane Systematic Reviews, 18-Jan-2012
Clozapine is widely used for people with schizophrenia. Although agranulocytosis, weight gain, and cardiac problems are serious problems associated with its use, hypersalivation, sometimes of a gross and socially unacceptable quantity, is also common (30-
- Pharmacological interventions for cognitive decline in people with Down syndrome
Cochrane Systematic Reviews, 29-Oct-2015
People with Down syndrome are vulnerable to developing dementia at an earlier age than the general population. Alzheimer's disease and cognitive decline in people with Down syndrome can place a significant burden on both the person with Down syndrome and
- Pharmacological interventions for drug-using offenders
Cochrane Systematic Reviews, 2-Jun-2015
The review represents one in a family of four reviews focusing on a range of different interventions for drug-using offenders. This specific review considers pharmacological interventions aimed at reducing drug use or criminal activity, or both, for illic
- Pharmacological interventions for epilepsy in people with intellectual disabilities
Cochrane Systematic Reviews, 2-Sep-2015
The prevalence of epilepsy among people with intellectual disabilities is much higher than in the general population. Seizures in this population are often complex and refractory to treatment and antiepileptic medication may have a profound effect upon be
- Pharmacological interventions for generalised itching (not caused by systemic disease or skin lesions) in pregnancy
Cochrane Systematic Reviews, 18-Feb-2016
Generalised itching is one of the most common dermatological symptoms in pregnant women. Having itchy skin during pregnancy may be very frustrating and can lead to poor sleep, exhaustion and impaired quality of life. There is a need for a systematic revie
- Pharmacological interventions for hypertension in children
Cochrane Systematic Reviews, 25-Jan-2014
Hypertension is a major risk factor for stroke, coronary artery disease and kidney damage in adults. There is a paucity of data on the long-term sequelae of persistent hypertension in children, but it is known that children with hypertension have evidence
- Pharmacological interventions for hypertensive emergencies
Cochrane Systematic Reviews, 12-Nov-2008
Hypertensive emergencies, marked hypertension associated with acute end-organ damage, are life-threatening conditions. Many anti-hypertensive drugs have been used in these clinical settings. The benefits and harms of such treatment and the best first-line
- Pharmacological interventions for ischaemia reperfusion injury in liver resection surgery performed under vascular control
Cochrane Systematic Reviews, 11-Aug-2009
Vascular occlusion used during elective liver resection to reduce blood loss results in significant ischaemia reperfusion (IR) injury. This in turn leads to significant postoperative liver dysfunction and morbidity. Various pharmacological drugs have been
- Pharmacological interventions for pain and sedation management in newborn infants undergoing therapeutic hypothermia
Cochrane Systematic Reviews, 10-Nov-2022
Newborn infants affected by hypoxic-ischemic encephalopathy (HIE) undergo therapeutic hypothermia. As this treatment seems to be associated with pain, and intensive and invasive care is needed, pharmacological interventions are often used. Moreover, painf
- Pharmacological interventions for pain in children and adolescents with life-limiting conditions
Cochrane Systematic Reviews, 11-Mar-2015
Pain is one of the most common symptoms in children and young people (CYP) with life-limiting conditions (LLCs) which include a wide range of diagnoses including cancer. The current literature indicates that pain is not well managed, however the evidence
- Pharmacological interventions for pain in patients with temporomandibular disorders
Cochrane Systematic Reviews, 6-Sep-2010
Temporomandibular disorders (TMD) are a group of disorders affecting the temporomandibular joints and the muscles of mastication. TMDs are treated with a wide range of drugs. The extent to which the use of these drugs is based upon evidence is unknown.
- Pharmacological interventions for people with borderline personality disorder
Cochrane Systematic Reviews, 14-Nov-2022
Among people with a diagnosis of borderline personality disorder (BPD) who are engaged in clinical care, prescription rates of psychotropic medications are high, despite the fact that medication use is off-label as a treatment for BPD. Nevertheless, peopl
- Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy
Cochrane Systematic Reviews, 14-Dec-2020
Acute kidney injury (AKI) is a major comorbidity in hospitalised patients. Patients with severe AKI require continuous renal replacement therapy (CRRT) when they are haemodynamically unstable. CRRT is prescribed assuming it is delivered over 24 hours. How
